Alligator Bioscience
0,297
SEK
+9,81 %
ATORX
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
3 investorer følger denne virksomhed
+9,81%
-56,2%
-76,91%
-73,34%
-56,97%
-50%
-78,73%
-94,99%
-98,54%
Alligator Bioscience is a research-based biotechnology company that uses patented technology to develop biological drug candidates in inflammation and cancer. The company is active in the former part of the drug development chain. Alligator Bioscience has a global technology platform and is active in a rapidly growing segment of the pharmaceutical market - protein drugs. The company was founded in 2001 and is headquartered in Lund, Sweden.
Læs mereMarkedsværdi
225,04 mio. SEK
Aktieomsætning
3,37 mio. SEK
Omsætning
58,11 mio.
EBIT %
-428,46 %
P/E
-
Udbytteafkast, %
-
Finanskalender
13.2
2025
Årsrapport '24
24.4
2025
Delårsrapport Q1'25
ViserAlle indholdstyper
Alligator Bioscience: BioStock: Alligator's CEO: "We are on track to secure a partnership"
Alligator Bioscience publishes financial calendar for 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools